Ftse Mib
34.396,01
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.505,56
0,18%
Bitcoin
65.204,88
0,54%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
05/06/201714:00PR Newswire (US)Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to ...NASDAQ:BPMCBlueprint Medicines Corporation
01/06/201714:00PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in JuneNASDAQ:BPMCBlueprint Medicines Corporation
17/05/201723:01PR Newswire (US)Blueprint Medicines to Present New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointest...NASDAQ:BPMCBlueprint Medicines Corporation
03/05/201723:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
03/05/201722:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
03/05/201713:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
03/05/201713:00PR Newswire (US)Blueprint Medicines Reports First Quarter 2017 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
28/04/201722:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BPMCBlueprint Medicines Corporation
28/04/201722:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BPMCBlueprint Medicines Corporation
26/04/201714:00PR Newswire (US)Blueprint Medicines to Report First Quarter 2017 Financial Results on Wednesday, May 3, 2017NASDAQ:BPMCBlueprint Medicines Corporation
10/04/201717:37Edgar (US Regulatory)Schedule 13gNASDAQ:BPMCBlueprint Medicines Corporation
04/04/201722:01PR Newswire (US)Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common ...NASDAQ:BPMCBlueprint Medicines Corporation
30/03/201700:55PR Newswire (US)Blueprint Medicines Announces Pricing of Public Offering of Shares of Common StockNASDAQ:BPMCBlueprint Medicines Corporation
29/03/201713:43Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BPMCBlueprint Medicines Corporation
29/03/201713:30PR Newswire (US)Blueprint Medicines Announces Proposed Public Offering of Shares of Common StockNASDAQ:BPMCBlueprint Medicines Corporation
27/03/201722:01PR Newswire (US)Blueprint Medicines to Present on BLU-285 and BLU-554 at Upcoming Scientific ConferencesNASDAQ:BPMCBlueprint Medicines Corporation
20/03/201721:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
20/03/201721:01PR Newswire (US)Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-667NASDAQ:BPMCBlueprint Medicines Corporation
09/03/201722:57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BPMCBlueprint Medicines Corporation
09/03/201722:46Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:BPMCBlueprint Medicines Corporation
09/03/201722:46Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BPMCBlueprint Medicines Corporation
09/03/201713:00PR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
02/03/201714:00PR Newswire (US)Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017NASDAQ:BPMCBlueprint Medicines Corporation
28/02/201714:00PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in MarchNASDAQ:BPMCBlueprint Medicines Corporation
15/02/201714:00PR Newswire (US)Blueprint Medicines to Present at 2017 RBC Capital Markets Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
30/01/201717:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BPMCBlueprint Medicines Corporation
09/01/201721:44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BPMCBlueprint Medicines Corporation
05/12/201601:30PR Newswire (US)Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic...NASDAQ:BPMCBlueprint Medicines Corporation
01/12/201600:01PR Newswire (US)Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastroin...NASDAQ:BPMCBlueprint Medicines Corporation
29/11/201600:01PR Newswire (US)Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced H...NASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

EU
IAPD
iShares Asia Pacific Div...
AQEU
COP
Casino Guichard Perrachon
LSE
ALBA
Alba Mineral Resources
LSE
IEBC
Ishrc Euro
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network